StonvexLoading…
StonvexStonvexStonvexCore line items from TDG's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2024 2024-09-30 | Annual 2023 2023-09-30 | Annual 2022 2022-09-30 | Annual 2021 2021-09-30 |
|---|---|---|---|---|
Revenue | $7.94B | $6.58B | $5.43B | $4.80B |
Operating Income | $3.53B | $2.92B | $2.21B | $1.69B |
Net Income | $1.71B | $1.30B | $866.00M | $680.00M |
EPS (Diluted) | $25.62 | $22.03 | $13.40 | $10.41 |
Total Assets | $25.59B | $19.97B | $18.11B | $19.32B |
Total Liabilities | $31.87B | $21.95B | $21.87B | $22.23B |
Cash & Equivalents | $6.26B | $3.47B | $3.00B | $4.79B |
Free Cash Flow OCF − CapEx | $1.88B | $1.24B | $829.00M | $808.00M |
Shares Outstanding | 57.80M | 57.20M | 58.20M | 58.40M |